Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Rankning i aktier
#4335
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Aktiekurs
$3.87
Marknadsvärde
$3.57B
Förändring (1 dag)
-1.64%
Förändring (1 år)
9.08%
Land
CN
Handel Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Kategori
Healthcare
Antal utestående aktier för Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Antal utestående aktier per October 2026: 0
Enligt de senaste finansiella rapporterna och aktiekursen för Hubei Jumpcan Pharmaceutical Co., Ltd. är det aktuella antalet utestående aktier 0. I slutet av October 2026 hade företaget 0 utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) från 2001 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2025 | 921.17M | 0.43% |
| 2024 | 917.23M | 0.08% |
| 2023 | 916.49M | 3.02% |
| 2022 | 889.65M | 0.16% |
| 2021 | 888.27M | 6.41% |
| 2020 | 834.78M | 2.44% |
| 2019 | 814.92M | 0.43% |
| 2018 | 811.47M | 0.23% |
| 2017 | 809.62M | 1.40% |
| 2016 | 798.45M | 2.34% |
| 2015 | 780.19M | 0.64% |
| 2014 | 775.21M | 27.04% |
| 2013 | 610.19M | 0.13% |
| 2012 | 609.41M | 341.10% |
| 2011 | 138.16M | -0.09% |
| 2010 | 138.28M | 30.05% |
| 2009 | 106.32M | -23.09% |
| 2008 | 138.24M | 0.03% |
| 2007 | 138.21M | 0.12% |
| 2006 | 138.05M | 0.00% |
| 2005 | 138.05M | 0.00% |
| 2004 | 138.05M | 0.00% |
| 2003 | 138.05M | 0.00% |
| 2002 | 138.05M | 0.00% |
| 2001 | 138.05M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
